CRISPRBIOTIC
LIVE

Serial Number

88511801

Owner

SNIPR Biome ApS

Attorney

Mark H. Tidman

Filing Date

Jul 12, 2019

Add to watchlist:

No watchlists yet
View on USPTO

CRISPRBIOTIC Trademark

Serial Number: 88511801 • Registration: 6083472

CRISPRBIOTIC is a trademark filed by SNIPR Biome ApS on July 12, 2019. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

SNIPR Biome ApS (6 trademarks)

Copenhagen 2100 , DK

Entity Type: 99

Trademark Details

Filing Date

July 12, 2019

Registration Date

June 23, 2020

Published for Opposition

April 7, 2020

Goods & Services

Pharmaceutical preparations, namely, antibacterial treatments, microbiome modulating treatments, anti-infective treatments and prophylaxis; medical preparations, namely, antibacterial treatments, microbiome modulating treatments, anti-infective treatments and prophylaxis, and medical diagnostics; veterinary preparations for antibacterial treatments, microbiome modulating treatments, anti-infective treatments and prophylaxis, and medical diagnostics; sanitary preparations for medical purposes; dietetic food and beverages adapted for medical or veterinary use; dietary supplements for human beings and animals; dietary supplements; antibiotic preparations; pharmaceutical preparations, namely, antiviral preparations; probiotic supplements; probiotic supplements for medical use; probiotic formulations for veterinary use, namely, probiotic nutritional supplements; probiotic formulations for medical use, namely, probiotic nutritional supplements; animal feed additives for use in animals feed to assist in digestion, growth or wellbeing; microbiome modulators for medical purposes, namely, targeted antimicrobial treatments for disease prevention or alteration; guided nuclease-based biocides; CRISPR-based biocides; pharmaceutical preparations for the treatment or prevention of disorders or diseases caused by bacteria

Medical services; diagnostic and prognostic medical services; veterinary services; medical analysis services relating to the treatment of persons in the nature of diagnostic and treatment counseling regarding the treatment of medical conditions and disease; advice; medical and health services relating to DNA, genetics and genetic pathogen testing, namely, genetic testing for medical purposes; genetic counseling

Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific and technological services, namely, scientific research, analysis and testing in the field of diseases and conditions associated with bacteria; industrial analysis and industrial research services; design and development of computer hardware and software; genetic microbiology and microbiome research; genetic engineering and services; design and development of hardware and software; clinical research; pharmaceutical research and development; development of pharmaceutical preparations and medicines; research and development services in the field of antibiotics; research and development of guided nuclease-based biocides; research and development of CRISPR-based biocides; research and development of CRISPR technology for the treatment of microbial diseases; clinical trials; clinical research; conducting clinical trials for pharmaceutical products; bacteriological research; viral research; biological research; scientific and medical screening and assaying; chemical analysis; chemical research

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jun 23, 2025 REM1
REGISTERED-PRINCIPAL REGISTER
Jun 23, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 7, 2020 NPUB
PUBLISHED FOR OPPOSITION
Apr 7, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 18, 2020 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 3, 2020 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 2, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 1, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 1, 2020 CRFA
ASSIGNED TO LIE
Jan 31, 2020 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 28, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 28, 2019 GNRN
NON-FINAL ACTION E-MAILED
Sep 28, 2019 GNRT
NON-FINAL ACTION WRITTEN
Sep 28, 2019 CNRT
ASSIGNED TO EXAMINER
Sep 28, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 18, 2019 NWOS
NEW APPLICATION ENTERED
Jul 16, 2019 NWAP